Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2008 Oct 6;52(12):4526–4527. doi: 10.1128/AAC.00882-08

Plasmid-Mediated 16S rRNA Methylases among Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Isolates

Béatrice Berçot 1, Laurent Poirel 1, Patrice Nordmann 1,*
PMCID: PMC2592896  PMID: 18838598

High levels of resistance to aminoglycosides conferred by plasmid-mediated mechanisms of resistance to aminoglycosides corresponding to 16S rRNA methylases have been reported since 2003 (3, 11). To date, six enzymes (ArmA, RmtA, RmtB, RmtC, RmtD, and NpmA) have been described, with ArmA being the most frequently identified methylase in Enterobacteriaceae (2). Associations between 16S rRNA methylase- and extended-spectrum β-lactamase (ESBL)-encoding genes such as the blaCTX-M genes have been reported (1, 7, 8). The aim of this study was to evaluate the prevalence of 16S rRNA methylase genes among ESBL-producing Enterobacteriaceae isolates recovered in a French university hospital.

A total of 373 nonduplicate ESBL-producing enterobacterial clinical isolates, collected at the Bicêtre hospital between January 2005 and December 2007, have been studied. Among them, 19 isolates (5.1%) were resistant to all clinically used aminoglycosides. That collection was screened by PCR for detection of 16S rRNA methylase-encoding genes (armA, rmtA, rmtB, rmtC, rmtD, and npmA), as previously described (2). Four armA-positive isolates were detected in 2005 (n = 2) and in 2007 (n = 2), in addition to a single rmtB-positive isolate from 2006. No isolate was positive for the rmtA, rmtC, rmtD, and npmA genes. The armA-positive isolates produced the ESBL CTX-M-3 (n = 3) or CTX-M-14 (n = 1), whereas the single rmtB-positive isolate was a CTX-M-14 producer. (CTX-M enzymes were searched for as described previously [6].) The low prevalence rate of 16S rRNA methylase determinants among ESBL producers (1.3%) observed here is similar to that reported from Taiwan (1.1%) (8) and higher than those reported from Belgium (0.12%) and Japan (0.03%) (1, 10), but lower than that from Korea (3%) (7).

All 16S rRNA methylase and ESBL determinants were transferred by conjugation and transformation using Escherichia coli J53 and TOP10 recipient strains after selection on Trypticase soy agar containing amikacin (50 μg/ml) and/or cefotaxime (8 μg/ml) (6). The 16S rRNA methylase-positive transformants expressed a high level of resistance to aminoglycosides (Table 1). In three isolates, the armA and blaCTX-M-3 genes were located on a same plasmid belonging to the IncL/M incompatibility group, as observed on the plasmid pCTX-M-3 (5), whereas the 16S rRNA methylase determinants were not physically linked to the ESBL genes for the two blaCTX-M-14-positive remaining isolates. Sequencing of the 16S rRNA methylase-encoding genes showed a perfect identity with previously reported genes. The complete PCR-mapped region of 11.6 kb containing the armA gene was entirely sequenced for two isolates, showing its association with ISCR1 inside a sul1-type integron structure, the same configuration observed in Tn1548 (4). The rmtB gene was located on an 11.4-kb region bracketed by two IS26 elements containing tnpA, blaTEM-1, intI1/groEL, and qepA and followed by an ISCR3 element, as observed on pHPA (9). Analysis of sequences flanking more closely the armA gene identified two novel insertion sequence elements, ISEc28 and ISEc29, belonging to the IS5 and IS4 families, respectively (http://www-is.biotoul.fr). No direct repeat sequence bracketing each of those IS elements and the overall ISEc28-armA-ISEc29 structure was identified.

TABLE 1.

MICs of antibiotics for clinical isolates producing 16S rRNA methylases, their corresponding armA- and rmtB-positive transformants, and E. coli TOP10a

Clinical isolate or transformantb 16S rRNA methylase or/and ESBLs MIC (μg/ml) ofc:
Plasmid size (kb) Incompatibility group plasmid type
AMK NET GEN TOB CTX CAZ IMP NOR CIP
E coli VOG rmtB and blaCTX-M-14 >256 >256 >256 >256 >32 6 0.19 >256 >32 80, 50
E. coli TOP10(pVOG1) rmtBd >256 >256 >256 >256 0.047 0.38 0.19 0.032 0.003 80 F
E. coli TOP10(pVOG2) blaCTX-M-14e 1.5 1.5 0.25 3 >32 2 0.19 <0.016 <0.002 50 NDf
E coli COP armA and blaCTX-M-14 >256 >256 >256 >256 >32 1 0.19 >256 >32 60, 38
E. coli TOP10(pCOP1) armA >256 >256 >256 >256 0.047 0.38 0.19 <0.016 <0.002 60 F
E. coli TOP10(pCOP2) blaCTX-M-14 1 0.125 0.125 0.19 8 1 0.19 <0.016 <0.002 38 I1
E coli MEZ armA and blaCTX-M-3 >256 >256 >256 >256 >32 3 0.19 >256 >32 120
E. coli TOP10(pMEZ) armA and blaCTX-M-3 >256 >256 >256 >256 >32 3 0.19 0.016 <0.002 120 L/M
Enterobacter cloacae BEH armA and blaCTX-M-3 >256 >256 >256 >256 >32 16 0.19 1 0.19 130
E. coli TOP10(pBEH) armA and blaCTX-M-3 >256 >256 >256 >256 >32 8 0.19 0.016 <0.002 130 L/M
Klebsiella pneumoniae DU armA and blaCTX-M-3 >256 >256 >256 >256 >32 2 0.19 0.75 0.125 120
E. coli TOP10(pDU) armA and blaCTX-M-3 >256 >256 >256 >256 >32 2 0.19 0.016 <0.002 120 L/M
E. coli TOP10 1 0.25 0.25 0.38 0.047 0.38 0.19 <0.016 <0.002
a

MICs of antibiotics were determined by using the Etest technique according to the manufacturer's recommendations. Analysis of plasmid content in the armA- and rmtB-positive isolates and their transformants was performed by the Kieser technique (7). The incompatibility group of plasmids was determined as previously described (2).

b

All clinical isolates were also resistant to sulfonamides, trimethoprim, chloramphenicol, tetracycline, and rifampin.

c

Antibiotic-resistant marker abbreviations: AMK, amikacin; NET, netilmicin; GEN, gentamicin; TOB, tobramycin; CTX, cefotaxime; CAZ, ceftazidime; IMP, imipenem; NOR, norfloxacin; and CIP, ciprofloxacin.

d

MICs for E. coli TOP10 transformants harboring pVOG1 expressing RmtB, TEM-1, and QepA.

e

MICs for E. coli TOP10 transformants harboring pVOG2 expressing CTX-M-14 and AAC(6′)-Ib.

f

ND, not determined.

This study underlines that the association on the same plasmid of 16S rRNA methylase- and ESBL-encoding genes remains rare. However, their localization on conjugative plasmids, and in some cases in association on the same plasmid, as observed here with CTX-M determinants, has the potential to further expand the threat of multidrug-resistant Enterobacteriaceae.

Nucleotide sequence accession numbers.

The nucleotide sequences of the regions surrounding qepA1 and rmtB have been submitted to the GenBank nucleotide sequence database under accession no. FJ183463 and FJ187822, respectively.

Acknowledgments

This work was financed by grants from the Ministère de l'Education Nationale et de la Recherche (grant UPRES, EA3539), Université Paris XI, Paris, France; from the European Community (DRESP2, 6th PCRD, LSHM-CT-2005-018705); and from INSERM.

We thank Y. Doi for the gift of the pPA95B1 plasmid carrying rmtD and M. J. Sanson-le Pors for constant support of B.B.

Footnotes

Published ahead of print on 6 October 2008.

REFERENCES

  • 1.Bogaerts, P., M. Galimand, C. Bauraing, A. Deplano, R. Vanhoof, R. De Mendonca, H. Rodriguez-Villalobos, M. Struelens, and Y. Glupczynski. 2007. Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium. J. Antimicrob. Chemother. 59:459-464. [DOI] [PubMed] [Google Scholar]
  • 2.Doi, Y., and Y. Arakawa. 2007. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45:88-94. [DOI] [PubMed] [Google Scholar]
  • 3.Galimand, M., P. Courvalin, and T. Lambert. 2003. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob. Agents Chemother. 47:2565-2571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Galimand, M., S. Sabtcheva, P. Courvalin, and T. Lambert. 2005. Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob. Agents Chemother. 49:2949-2953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gołębiewski, M., I. Kern-Zdanowicz, M. Zienkiewicz, M. Adamczyk, J. Zyliǹska, A. Baraniak, M. Gniadkowski, J. Bardowski, and P. Ceglowski. 2007. Complete nucleotide sequence of the pCTX-M3 plasmid and its involvement in spread of the extended-spectrum β-lactamase gene blaCTX-M-3. Antimicrob. Agents Chemother. 51:3789-3795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lartigue, M.-F., C. Zinsius, A. Wenger, J. Bille, L. Poirel, and P. Nordmann. 2007. Extended-spectrum β-lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51:2855-2860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lee, H., D. Yong, J. H. Yum, K. H. Roh, K. Lee, K. Yamane, Y. Arakawa, and Y. Chong. 2006. Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea. Diagn. Microbiol. Infect. Dis. 56:305-312. [DOI] [PubMed] [Google Scholar]
  • 8.Wu, J. J., H. M. Chen, W. C. Ko, H. M. Wu, S. H. Tsai, and J. J. Yan. 2008. Prevalence of extended-spectrum β-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66). Diagn. Microbiol. Infect. Dis. 60:169-175. [DOI] [PubMed] [Google Scholar]
  • 9.Yamane, K., J.-I. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yamane, K., J. Wachino, S. Suzuki, N. Shibata, H. Kato, K. Shibayama, K. Kimura, K. Kai, S. Ishikawa, Y. Ozawa, T. Konda, and Y. Arakawa. 2007. 16S rRNA methylase-producing, gram-negative pathogens, Japan. Emerg. Infect. Dis. 13:642-646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yokoyama, K., Y. Doi, K. Yamane, H. Kurokawa, N. Shibata, K. Shibayama, T. Yagi, H. Kato, and Y. Arakawa. 2003. Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362:1888-1893. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES